Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE

по Eastell, R., Mitlak, B. H., Wang, Y., Hu, M., Fitzpatrick, L. A., Black, D. M.
Опубликовано в: Osteoporos Int (2019)

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial

по Watts, N.B., Dore, R.K., Baim, S., Mitlak, B., Hattersley, G., Wang, Y., Rozental, T.D., LeBoff, M.S.
Опубликовано в: Osteoporos Int (2020)

Tools in the assessment of sarcopenia

по Cooper, C, Fielding, R, Visser, M, van Loon, LJ, Rolland, Y, Orwoll, E, Reid, K, Boonen, S, Dere, W, Epstein, S, Mitlak, B, Tsouderos, Y, Sayer, AA, Rizzoli, R, Reginster, JY, Kanis, JA
Опубликовано 2013

Treatment of osteoporosis in men

по Kaufman, J.-M., Reginster, J.-Y., Boonen, S., Brandi, M. L., Cooper, C., Dere, W., Devogelaer, J.-P., Diez-Perez, A., Kanis, J. A., McCloskey, E., Mitlak, B., Orwoll, E., Ringe, J.D., Weryha, G., Rizzoli, R.
Опубликовано 2012